Each year the Novozymes Prize is awarded by the Novo Nordisk Foundation to recognize outstanding European research or technology contributions that benefit the development of biotechnological science for innovative solutions.
The 2017 Novozymes Prize was awarded to Virginijus Šikšnys from the Institute of Biotechnology at Vilnius University and Professor Emmanuelle Charpentier from the Max Planck Institute for Infection Biology. The two researchers receive the Prize for their groundbreaking research, which has had a crucial role in developing the genetic tool CRISPR-Cas9.
You are invited to join the Novozymes Prize Symposium taking place in the Lecture Hall at the Novo Nordisk Foundation on 23 February 2018.
Read more and sign up HERE